JP MORGAN/CALL/ELI LILLY & CO/750/0.01/20.09.24 | Real-time Bid/Ask 01:04:59 04/07/2024 pm IST | ||
| 1.47 EUR / 1.52 EUR | -8.84% |
|
| Current month | -1.80% | ||
| 1 month | +62.38% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
ELI LILLY AND COMPANY
Latest news about ELI LILLY AND COMPANY
| Date | Price | Change |
|---|---|---|
| 03/24/03 | 1.64 | +7.89% |
| 02/24/02 | 1.52 | -6.75% |
| 01/24/01 | 1.63 | -2.40% |
| 28/24/28 | 1.67 | +4.37% |
| 27/24/27 | 1.6 | +7.38% |
Delayed Quote Börse Stuttgart
Last update July 03, 2024 at 02:44 pm IST
More quotesStatic data
| Product type | Warrants |
|---|---|
| Buy / Sell | CALL |
| Underlying | ELI LILLY AND COMPANY |
| Issuer | J.P. Morgan |
| WKN | JK2EXZ |
| ISIN | DE000JK2EXZ3 |
| Date issued | 08/02/2024 |
| Strike | 750 $ |
| Maturity | 20/09/2024 (79 Days) |
| Parity | 100 : 1 |
| Emission price | 0.51 € |
| Emission volume | N/A |
| Settlement | règlement en espèces |
| Currency | EUR |
Technical Indicators
| Highest since issue | 1.67 € |
|---|---|
| Lowest since issue | 0.5 € |
| Delta | 0.91x |
| Omega | 5.052 |
| Premium | 1.48x |
| Gearing | 5.57x |
| Moneyness | 1.197 |
| Difference Strike | -148.1 $ |
| Difference Strike % | -19.75% |
| Spread | 0.05 € |
| Spread % | 3.29% |
| Theoretical value | 1.495 |
| Implied Volatility | 32.65 % |
| Total Loss Probability | 11.82 % |
| Intrinsic value | 1.372 |
| Present value | 0.1228 |
| Break even | 911.35 € |
| Theta | -0.01x |
| Vega | 0.01x |
| Rho | 0.01x |
Company Profile
Eli Lilly and Company is one of the world's leading pharmaceutical groups. Net sales break down by therapeutic field as follows:
- endocrinology (57.7%): products for treating osteoporosis, diabetes, and growth problems;
- oncology (19.5%);
- immunology diseases (11.1%);
- neurology (8.4%): primarily drugs used in treating depression and schizophrenia;
- other (3.3%).
Net sales are distributed geographically as follows: the United States (63.9%), Europe (18.1%), Japan (4.9%), China (4.5%) and other (8.6%).
Sector
-
Consensus: Eli Lilly and Company
Sell
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
898.1
USD
Average target price
870.3
USD
Spread / Average Target
-3.10%
- Stock Market
- Warrants
- Warrant
